Literature DB >> 26763454

Epidermolysis Bullosa Acquisita Develops in Dominant Dystrophic Epidermolysis Bullosa.

Ryota Hayashi1, Ken Natsuga2, Mika Watanabe2, Hiroaki Iwata2, Satoru Shinkuma2, Akiko Ito1, Yukiko Masui1, Masaaki Ito1, Yutaka Shimomura3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26763454     DOI: 10.1038/JID.2015.370

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  5 in total

Review 1.  The Immunogenetics of Autoimmune Blistering Diseases.

Authors:  Diana Kneiber; Eric H Kowalski; Kyle T Amber
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Case Report: Diagnostic and Therapeutic Challenges in Severe Mechanobullous Epidermolysis Bullosa Acquisita.

Authors:  Franziska Schauer; Alexander Nyström; Manfred Kunz; Stefanie Hübner; Sarah Scholl; Ioannis Athanasiou; Svenja Alter; Judith Fischer; Cristina Has; Dimitra Kiritsi
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

3.  Case report: bullous pemphigoid development underlies dystrophic epidermolysis bullosa disease worsening.

Authors:  Giovanni Di Zenzo; Giovanna Floriddia; Sabrina Rossi; Feliciana Mariotti; Alessia Primerano; Angelo Giuseppe Condorelli; Biagio Didona; Daniele Castiglia
Journal:  Front Immunol       Date:  2022-07-29       Impact factor: 8.786

4.  Occurrence of autoantibodies against skin proteins in patients with hereditary epidermolysis bullosa predisposes to development of autoimmune blistering disease.

Authors:  Saskia Lehr; Felicitas Felber; Iliana Tantcheva-Poór; Christina Keßler; Rüdiger Eming; Alexander Nyström; Marta Rizzi; Dimitra Kiritsi
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

Review 5.  A Review of Acquired Autoimmune Blistering Diseases in Inherited Epidermolysis Bullosa: Implications for the Future of Gene Therapy.

Authors:  Payal M Patel; Virginia A Jones; Christy T Behnam; Giovanni Di Zenzo; Kyle T Amber
Journal:  Antibodies (Basel)       Date:  2021-05-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.